Cytomorphologic overlap of differentiated thyroid carcinoma and lung adenocarcinoma and diagnostic value of TTF-1 and TGB on cytologic material

Authors

  • Srividya Sathiyamoorthy M.B.B.S., M.S.,

    1. Department of Pathology, Division of Cytopathology, The Johns Hopkins Hospital, Baltimore, Maryland
    Search for more papers by this author
  • Zahra Maleki M.D.

    Corresponding author
    1. Department of Pathology, Division of Cytopathology, The Johns Hopkins Hospital, Baltimore, Maryland
    • Correspondence to: Zahra Maleki, M.D., Department of Pathology/Division of Cytopathology, The Johns Hopkins Hospital, PATH 406, 600 North Wolfe Street, Baltimore, MD 21287. E-mail: zmaleki1@jhmi.edu

    Search for more papers by this author

  • This work was presented as a poster in the 2012 USCAP meeting in Vancouver, Canada in March 2012.

Abstract

Thyroid carcinomas and lung adenocarcinoma share cytomorphological features yet have different prognoses. Thyroid Transcription Factor-1 (TTF-1) is an immunohistochemical (IHC) marker used to confirm pulmonary and thyroid carcinoma, while Thyroglobulin (TGB) is expressed by thyroid carcinoma.

 The cytopathology archive of The Johns Hopkins Hospital was searched for cases of lung adenocarcinoma versus thyroid carcinoma with TTF-1 and TGB IHC.

 Forty-four cases of lung adenocarcinoma (25) and thyroid carcinoma (19) were retrieved. One was metastatic lung adenocarcinoma to the thyroid and three were metastatic papillary thyroid carcinoma (PTC) to the lung. The initial interpretation of two cases from bony lesions was metastatic lung adenocarcinoma. In light of additional clinical information and TGB immunostain, the diagnoses of these two cases changed to metastatic thyroid carcinoma.

 TTF-1 and TGB is a small immunostain panel that can differentiate lung adenocarcinoma from thyroid carcinoma and prevent misdiagnosis and its consequences. Diagn. Cytopathol. 2014;42:5–10. © 2013 Wiley Periodicals, Inc.

Ancillary